SPDR Series Trust S&P Biotech (XBI) Surged 5.59% or 4.97 To Price $93.89 On Monday


SPDR Series Trust S&P Biotech (XBI) surged 5.59% or 4.97 to $93.89. It is approximately 8.73 million shares traded, which is 193.29% compare to the average total volume 4.52 million. The market cap of XBI is $4.84 billion. The year to date change is 1.96%. The 52 week price range is from $61.14 to $93.89. Price of XBI have changed -0.78% during last week. It have changed 7.03% over last month, 5.28% over last 3 months, 10.09% over last 6 months and 42.59% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for XBI is 83.83. It is -10.71% below current price. The 200-day Moving Averages for XBI is 78.82. It is -16.05% below current price. The 52-week High is 93.89. The stock hits 52-week high today. The 52-week Low is 61.14. It is -34.88% from current price.

There are some statistics of XBI. It is has market cap $4.84 billion. The share outstanding is 51.60 million. The average volume is 4.52 million. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of XBI is -20.78%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of XBI is -23.55%.


Tags:

Share this post